Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 13, 2019

Total Value ($000): $145,241 (100.0% shares, 0.0% debt)

Holdings (25)

LGND LIGAND PHARMACEUTICALS 13.2%
Value ($000) $19,119 Shares 167,487 Est. Cost $75.54 Unrealized -2.5%
VNDA VANDA PHARMACEUTICALS INC 13.0%
Value ($000) $18,908 Shares 1,341,943 Est. Cost $21.07 Unrealized -24.5%
AMARIN CORP PLC -ADR 12.4%
Value ($000) $18,044 Shares 930,604 Est. Cost $3.01 Unrealized
BIODELIVERY SCIENCES INTL 8.9%
Value ($000) $12,855 Shares 2,764,475 Est. Cost $3.48 Unrealized
ADAMAS PHARMACEUTICALS INC 6.1%
Value ($000) $8,826 Shares 1,423,578 Est. Cost $6.83 Unrealized
APOLLO ENDOSURGERY INC 5.8%
Value ($000) $8,387 Shares 2,580,518 Est. Cost $4.60 Unrealized
NEOS THERAPEUTICS INC 4.4%
Value ($000) $6,413 Shares 4,971,014 Est. Cost $1.82 Unrealized
ALIMERA SCIENCES INC 3.9%
Value ($000) $5,731 Shares 6,439,498 Est. Cost $1.18 Unrealized
CPIX CUMBERLAND PHARMACEUTICALS 3.8%
Value ($000) $5,553 Shares 871,762 Est. Cost $5.84 Unrealized +3.9%
ENTA ENANTA PHARMACEUTICALS INC 3.8%
Value ($000) $5,526 Shares 65,484 Est. Cost $89.72 Unrealized +0.3%
IVERIC BIO INC 3.7%
Value ($000) $5,348 Shares 4,113,522 Est. Cost $1.30 Unrealized
HTG MOLECULAR DIAGNOSTICS 3.2%
Value ($000) $4,624 Shares 2,785,585 Est. Cost $2.67 Unrealized
OPIANT PHARMACEUTICALS INC 2.9%
Value ($000) $4,180 Shares 315,468 Est. Cost $16.03 Unrealized
XOMA XOMA CORP 2.8%
Value ($000) $4,019 Shares 270,449 Est. Cost $13.89 Unrealized +8.1%
APTEVO THERAPEUTICS INC 2.4%
Value ($000) $3,478 Shares 3,922,891 Est. Cost $0.90 Unrealized
CTI BIOPHARMA CORP 2.3%
Value ($000) $3,355 Shares 3,904,400 Est. Cost $3.06 Unrealized
OXFORD IMMUNOTEC GLOBAL PLC 2.2%
Value ($000) $3,136 Shares 227,900 Est. Cost $15.14 Unrealized
AFFIMED NV 1.4%
Value ($000) $2,054 Shares 715,754 Est. Cost $3.04 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.1%
Value ($000) $1,550 Shares 651,211 Est. Cost $4.50 Unrealized
VIVEVE MEDICAL INC 0.9%
Value ($000) $1,293 Shares 3,403,402 Est. Cost $6.92 Unrealized
INTERPACE DIAGNOSTICS GROUP 0.9%
Value ($000) $1,271 Shares 1,753,184 Est. Cost $0.79 Unrealized
MATINAS BIOPHARMA HOLDINGS I 0.4%
Value ($000) $573 Shares 668,615 Est. Cost $1.09 Unrealized
STRONGBRIDGE BIOPHARMA PLC 0.3%
Value ($000) $508 Shares 162,244 Est. Cost $4.98 Unrealized
NOVELION THERAPEUTICS INC 0.3%
Value ($000) $383 Shares 491,096 Est. Cost $0.78 Unrealized
MOTUS GI HOLDINGS INC 0.1%
Value ($000) $107 Shares 35,205 Est. Cost $3.04 Unrealized